Navigation Links
Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
Date:8/23/2007

DALLAS Aug. 23, 2007 Surgeons specializing in laparoscopic procedures at UT Southwestern Medical Center have successfully removed a patients kidney by performing a unique nephrectomy entirely through the belly button.

Dr. Jeffrey Cadeddu, associate professor of urology and radiology, performed the single keyhole access surgery, the first of its kind involving a kidney. The entire procedure was completed with only one incision and will leave the patient with a barely noticeable scar tucked in the umbilicus, or navel.

We are proud of this novel surgical technique, said Dr. Cadeddu, who leads the Clinical Center for Minimally Invasive Treatment of Urologic Cancer. Laparoscopic surgery already gives patients smaller incisions, less pain and a faster recovery. This transumbilical technique is a further extension of laparoscopic surgery, which essentially removes scarring from the patients skin.

Dr. Claus Roehrborn, chairman of urology at UT Southwestern, said, Single-access surgery is the next major advance in making surgery even less invasive. For Dr. Cadeddu to be the first to perform such a surgery and remove the intact organ in this manner is a testament to the tremendous advances in clinical medicine that are being made at UT Southwestern and in our department. Dr. Roehrborn is director of the Sarah M. and Charles E. Seay Center for Pediatric Urology.

Dr. Cadeddu performed the surgery with a newly developed set of high-dexterity instrumentation known as RealHand, manufactured by Novare Surgical Systems. The instruments enable surgeons to perform more difficult maneuvers that otherwise could not be completed. The high-dexterity instruments make it easy to manipulate and complete tasks regardless of whether the appliance is positioned over, under or around internal organs.

Using the high-dexterity instrumentation, Dr. Cadeddu, who does not receive support from Novare, was able to place all of the standard lapar
'/>"/>

Contact: Erin Prather Stafford
erin.pratherstafford@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert

1

GOOD

Page: 1 2

Related medicine news :

1. Bypass Heart Surgery Performed Without General Anesthesia
2. NEW ROBOTIC SURGERY ARM APPROVED BY FDA
3. Thyroid hormone treatment hastens recovery after cardiac surgery
4. Indian Prime Minister has successful Knee Replacement Surgery
5. Two doctors suspended for wrong brain surgery
6. Researchers urge caution in using ear tube surgery
7. Surgery made simple
8. Sweaty palms syndrome can be cured by surgery
9. Surviving surgery
10. Waking during surgery
11. Supplement helps cardiac surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
...s that a child’s race may be a factor in determini...ated with environmental tobacco smoke (ETS). //The... asthma, who are exposed to ETS, have significantl... their Caucasian counterparts. “African American ...
...o experience a change in health caused by an unint...thout insurance are more likely to have difficulty...ely to experience larger declines in short-term he...ey, Ph.D., of the Urban Institute, Washington, D.C...
...ean of University of Massachusetts Medical School ...ealth reasons//. It was reported that he has devel...le for the merger of state hospital and the privat...up the $ 100 million research lab there. In 1982, ...
...kesh Haikerwal, said today the Government must ame...able// elderly Australians from abuse in aged care...ecurity and Protection) Bill 2007, which the Gover... calls for the compulsory reporting of any physica...
Other Medicine News:Health News:Race Affects Tobacco Absorption in Children 2Health News:Uninsured Often Receive Less Medical Care 2Health News:AMA Urges Government To Amend Aged Care Legislation 2
(Date:8/14/2008)...all/ -- Pharmasset, Inc.,(Nasdaq: VRUS ), a clini...overing, developing and commercializing novel drug...nancial results for the third fiscal,quarter ended...ributable to,common stockholders of $15.0 million,...d June 30, 2008, as compared to a net loss attribu...
(Date:8/14/2008)...nable Targeting and Increase Spee.... and HEIDELBERG, Germany, Aug. 14 /-...titute (TGen) today announced,the formation of a c...ration-Sequencing equipment in conjunction with fe..., febit,s HybSelect(TM) Technology enables select...
(Date:8/13/2008)...As biotechnology,pharmaceutical and medical devic...nd their own borders to other parts of the world, ...mplicated regulatory environments,challenge those ...lysis by,Aon Corporation (NYSE: AOC ). Aon,s 2008... a visual representation of the complex insurance,...
(Date:8/13/2008)... to automatically measure QT inter...lif., Aug. 13 /- NewCardio,...stic and services company, today,revealed the resu...no(TM),(the "NCE3 Study"). The study was led by an...t with extensive experience in pharmaceutical clin...
Breaking Medicine Technology:Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 2Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 3Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 4Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 5Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 6Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 7Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 8Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 9febit and TGen Collaborate to Study New DNA Capture Method 2febit and TGen Collaborate to Study New DNA Capture Method 3Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 2Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 3Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 4NewCardio Announces Positive Results From Third Clinical Validation Study 2NewCardio Announces Positive Results From Third Clinical Validation Study 3NewCardio Announces Positive Results From Third Clinical Validation Study 4NewCardio Announces Positive Results From Third Clinical Validation Study 5Molecular alliance that sustains embryonic stem cell state 13467 1Molecular alliance that sustains embryonic stem cell state 13467 2Molecular alliance that sustains embryonic stem cell state 13467 3Non Polyp Colon Lesions Hard to Detect 13462 1Non Polyp Colon Lesions Hard to Detect 13462 2Non Polyp Colon Lesions Hard to Detect 13462 3Sticky blood protein yields clues to autism 13458 1Sticky blood protein yields clues to autism 13458 2Sticky blood protein yields clues to autism 13458 3Specialists in drug discovery and development convene 13455 1Specialists in drug discovery and development convene 13455 2
...t Study in American Heart Journal , ,WINNIPEG, Ma...mex:MCU), a cardiovascular focused, biopharmaceuti...llow-up results from the,STRATEGY (Single High-Dos...us Abciximab and Bare Metal Stent In Acute Myocard...dition of the Journal,of the American College of C...
...1, 2007 /PRNewswire/ -- Phase 3 results,from the R...an,etexilate once daily, administered for an avera...o administered for an average of 33,days, in preve...ortality after total hip replacement surgery. In t...ith dabigatran etexilate was,similar to enoxaparin...
Other Medicine Technology:Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 2Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 3Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 4Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 5Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 2Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 3Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 4Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 5
...e) injection was introduced in 1988, it ushered in...gnetic resonance imaging (MRI). It became the worl...e product is still a market leader with indication...n over 85 countries and has established a positive...
Up to 20% of the 17 million echocardiograms performed annually in the U.S. are suboptimal. Activated DEFINITY increases the power of echocardiography, obtaining clearer images of the heart than with
...neration ultrasound medical diagnostic product wit...ders of the heart. This allows doctors to see abno...asound scanning procedure, enabling more accurate ...viding guidance for the selection and monitoring o...
...isosmolar contrast medium (IOCM™) available ...ood, VISIPAQUE was designed for patient safety and...um formulated with sodium and calcium in a ratio e...A approval for use in children over one year of ag...
Medicine Products: